These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

500 related articles for article (PubMed ID: 30790054)

  • 1. Impact of chronic lung allograft dysfunction, especially restrictive allograft syndrome, on the survival after living-donor lobar lung transplantation compared with cadaveric lung transplantation in adults: a single-center experience.
    Sugimoto S; Yamamoto H; Kurosaki T; Otani S; Okazaki M; Yamane M; Toyooka S; Oto T
    Surg Today; 2019 Aug; 49(8):686-693. PubMed ID: 30790054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Chronic Lung Allograft Dysfunction after Living-donor Lobar Lung Transplantation].
    Sugimoto S; Tanaka S; Miyoshi K; Toyooka S
    Kyobu Geka; 2022 Apr; 75(4):297-301. PubMed ID: 35342161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Restrictive allograft dysfunction rather than bronchiolitis obliterans syndrome had a major impact on the overall survival after living-donor lobar lung transplantation.
    Matsubara K; Otani S; Yamamoto H; Hashimoto K; Tanaka S; Shien K; Suzawa K; Miyoshi K; Yamamoto H; Okazaki M; Sugimoto S; Toyooka S
    Surg Today; 2024 Apr; 54(4):317-324. PubMed ID: 37523071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Graft dysfunction immediately after reperfusion predicts short-term outcomes in living-donor lobar lung transplantation but not in cadaveric lung transplantation.
    Mizota T; Miyao M; Yamada T; Sato M; Aoyama A; Chen F; Date H; Fukuda K
    Interact Cardiovasc Thorac Surg; 2016 Mar; 22(3):314-20. PubMed ID: 26705301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emphysematous changes and lower levels of plasma irisin are associated with bronchiolitis obliterans syndrome after bilateral living-donor lobar lung transplantation.
    Shiotani T; Sugimoto S; Yamamoto H; Miyoshi K; Otani S; Suzawa K; Yamamoto H; Okazaki M; Yamane M; Toyooka S
    Surg Today; 2022 Feb; 52(2):294-305. PubMed ID: 34251508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unilateral chronic lung allograft dysfunction is a characteristic of bilateral living-donor lobar lung transplantation.
    Miyamoto E; Chen F; Aoyama A; Sato M; Yamada T; Date H
    Eur J Cardiothorac Surg; 2015 Sep; 48(3):463-9. PubMed ID: 25468952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Airway complications have a greater impact on the outcomes of living-donor lobar lung transplantation recipients than cadaveric lung transplantation recipients.
    Sugimoto S; Yamane M; Otani S; Kurosaki T; Okahara S; Hikasa Y; Toyooka S; Kobayashi M; Oto T
    Surg Today; 2018 Sep; 48(9):848-855. PubMed ID: 29680912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Living-donor lobar lung transplantation provides similar survival to cadaveric lung transplantation even for very ill patients†.
    Date H; Sato M; Aoyama A; Yamada T; Mizota T; Kinoshita H; Handa T; Tanizawa K; Chin K; Minakata K; Chen F
    Eur J Cardiothorac Surg; 2015 Jun; 47(6):967-72; discussion 972-3. PubMed ID: 25228745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of de novo donor-specific antibodies between living and cadaveric lung transplantation.
    Gochi F; Chen-Yoshikawa TF; Kayawake H; Ohsumi A; Tanaka S; Yamada Y; Yutaka Y; Nakajima D; Hamaji M; Yurugi K; Hishida R; Date H
    J Heart Lung Transplant; 2021 Jul; 40(7):607-613. PubMed ID: 34078558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term outcomes of living-donor lobar lung transplantation.
    Sugimoto S; Date H; Miyoshi K; Otani S; Ishihara M; Yamane M; Toyooka S
    J Thorac Cardiovasc Surg; 2022 Aug; 164(2):440-448. PubMed ID: 34895720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Restrictive allograft syndrome (RAS): a novel form of chronic lung allograft dysfunction.
    Sato M; Waddell TK; Wagnetz U; Roberts HC; Hwang DM; Haroon A; Wagnetz D; Chaparro C; Singer LG; Hutcheon MA; Keshavjee S
    J Heart Lung Transplant; 2011 Jul; 30(7):735-42. PubMed ID: 21419659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Living-donor lobar lung transplantation.
    Date H
    J Heart Lung Transplant; 2024 Jan; 43(1):162-168. PubMed ID: 37704161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lung perfusion scintigraphy to detect chronic lung allograft dysfunction after living-donor lobar lung transplantation.
    Yamamoto H; Sugimoto S; Kurosaki T; Miyoshi K; Otani S; Okazaki M; Yamane M; Oto T; Toyooka S
    Sci Rep; 2020 Jun; 10(1):10595. PubMed ID: 32601414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Native lung complications after living-donor lobar lung transplantation.
    Mineura K; Chen-Yoshikawa TF; Tanaka S; Yamada Y; Yutaka Y; Nakajima D; Ohsumi A; Hamaji M; Menju T; Date H
    J Heart Lung Transplant; 2021 May; 40(5):343-350. PubMed ID: 33602629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytomegalovirus infection in living-donor and cadaveric lung transplantations.
    Ohata K; Chen-Yoshikawa TF; Takahashi K; Aoyama A; Motoyama H; Hijiya K; Hamaji M; Menju T; Sato T; Sonobe M; Takakura S; Date H
    Interact Cardiovasc Thorac Surg; 2017 Nov; 25(5):710-715. PubMed ID: 29049752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative chest CT for subtyping chronic lung allograft dysfunction and its association with survival.
    Horie M; Salazar P; Saito T; Binnie M; Brock K; Yasufuku K; Azad S; Keshavjee S; Martinu T; Paul N
    Clin Transplant; 2018 May; 32(5):e13233. PubMed ID: 29637624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of a post-transplant chronic lung allograft dysfunction classification system.
    Van Herck A; Verleden SE; Sacreas A; Heigl T; Vanaudenaerde BM; Dupont LJ; Yserbyt J; Verbeken EK; Neyrinck AP; Van Raemdonck D; Verleden GM; Vos R
    J Heart Lung Transplant; 2019 Feb; 38(2):166-173. PubMed ID: 30391199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognostic nutritional index is correlated negatively with the lung allocation score and predicts survival after both cadaveric and living-donor lobar lung transplantation.
    Yamamoto H; Sugimoto S; Soh J; Shiotani T; Miyoshi K; Otani S; Okazaki M; Yamane M; Toyooka S
    Surg Today; 2021 Oct; 51(10):1610-1618. PubMed ID: 33582840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of living-donor lobar lung transplantation and cadaveric lung transplantation for pulmonary hypertension.
    Kayawake H; Tanaka S; Yamada Y; Baba S; Kinoshita H; Yamazaki K; Ikeda T; Minatoya K; Yutaka Y; Hamaji M; Ohsumi A; Nakajima D; Date H
    Eur J Cardiothorac Surg; 2023 Apr; 63(4):. PubMed ID: 36723127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bronchial healing after living-donor lobar lung transplantation.
    Toyooka S; Yamane M; Oto T; Sano Y; Okazaki M; Date H
    Surg Today; 2009; 39(11):938-43. PubMed ID: 19882314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.